Gary Taylor

Stock Analyst at TD Cowen

(2.55)
# 2,324
Out of 4,984 analysts
146
Total ratings
51.52%
Success rate
0.43%
Average return

Stocks Rated by Gary Taylor

Bath & Body Works
Nov 26, 2024
Maintains: Buy
Price Target: $40$42
Current: $25.73
Upside: +63.23%
P3 Health Partners
Nov 20, 2024
Maintains: Hold
Price Target: $45$13
Current: $8.66
Upside: +44.34%
agilon health
Nov 11, 2024
Maintains: Hold
Price Target: $6$2
Current: $1.14
Upside: +75.44%
Humana
Nov 4, 2024
Maintains: Hold
Price Target: $261$268
Current: $269.39
Upside: -0.52%
Alignment Healthcare
Oct 31, 2024
Maintains: Buy
Price Target: $10$13
Current: $16.68
Upside: -22.06%
HCA Healthcare
Oct 28, 2024
Maintains: Buy
Price Target: $450$440
Current: $399.39
Upside: +10.17%
UnitedHealth Group
Oct 18, 2024
Maintains: Buy
Price Target: $601$609
Current: $341.61
Upside: +78.27%
Centene
Jul 31, 2024
Maintains: Buy
Price Target: $80$89
Current: $32.02
Upside: +177.95%
Molina Healthcare
Jul 29, 2024
Maintains: Buy
Price Target: $351$378
Current: $176.32
Upside: +114.38%
Universal Health Services
Jul 26, 2024
Maintains: Hold
Price Target: $183$220
Current: $187.39
Upside: +17.40%
Maintains: Hold
Price Target: $139$150
Current: $128.00
Upside: +17.19%
Maintains: Buy
Price Target: $101$91
Current: $21.92
Upside: +315.15%
Maintains: Outperform
Price Target: $30$26
Current: $22.21
Upside: +17.06%
Upgrades: Outperform
Price Target: $39$35
Current: $21.79
Upside: +60.62%
Maintains: Outperform
Price Target: $564$585
Current: $308.48
Upside: +89.64%
Maintains: Market Perform
Price Target: $3$6
Current: $17.77
Upside: -66.24%
Maintains: Outperform
Price Target: $10$8
Current: $5.15
Upside: +55.34%
Upgrades: Outperform
Price Target: $242$329
Current: $296.59
Upside: +10.93%
Upgrades: Market Perform
Price Target: $7$3
Current: $3.07
Upside: -2.28%
Initiates: Market Perform
Price Target: $17
Current: $4.98
Upside: +241.37%
Downgrades: Underweight
Price Target: $28$20
Current: $183.47
Upside: -89.10%
Maintains: Neutral
Price Target: $33$20
Current: $16.18
Upside: +23.61%
Downgrades: Underweight
Price Target: n/a
Current: $2.95
Upside: -